Tag: ESO

Understanding the role of biomarkers in PCa treatment

With the current emphasis on providing personalised treatment to prostate cancer patients, expectations on the role of biomarkers may have been too high and experts say delivering optimal management requires understanding the usefulness of biomarkers within the context of...